Medical journal Lung Disease News endorses vaping

Social media and mainstream news outlets are constantly peddling poorly researched vaping studies that are essentially nothing more than junk science.  From non-peer-reviewed clinical trials claiming that vaping is just as deadly as conventional smoking to outlandish assertions that vaping increases the risks of heart attacks, nothing is considered too vile to publish these days.  So, when a major medical publication goes against the grain and officially endorse vaping, it is truly noteworthy.

Lung Disease News (LDN) is just such an organization.  Based in the United Kingdom, the medical journal issued a press release in mid-2017 entitled, E-Cigarettes carry much less risk of lung cancer than cigarette smoke, study finds.  In the article, the journal notes that both the scientific community and the general public are “divided” over the associated health benefits of vaping.  By referencing several research studies that LDN deems scientifically valid, they issued the following statement.

“The team concluded that cigarettes posed the highest lifetime cancer risk, followed by heat-not-burn devices, then e-cigarettes and finally medicinal nicotine inhalers.”

One of the primary studies referenced in the LDN endorsement is led by Dr. William E. Stephens of the University of St. Andrews.  The Stephens team wanted to determine the cancer risks associated with multiple carcinogenic compounds found in combustible tobacco smoke before calculating the comparable levels of risks associated with e-cigs, heat-not-burn technology, and medicinal nicotine inhalers.  Yes, medicinal nicotine is a thing.

Related Article: Public health expert says nothing substantially ‘wrong with nicotine’ in vaping

During the course of the trial, the researchers even invented a new type of contraption that measures the toxicity levels of aerosols.  All experiments were ultimately compared to the biomarkers of regular smokers.  What the researchers discovered is that the vapor from electronic cigarettes is “less than 1 percent of cigarette smoke.”

“Each of the aerosols had different cancer potencies, they discovered. Cigarette smoke had the highest. potency. Most e-cigarettes had cancer potencies that were less than 1 percent of cigarette smoke, although a small minority had much higher potency than the others.”

The LDN even addresses the issue of the “small minority” of vaping devices and studies claiming higher toxicities.  And just like many world-famous scientists like Dr. Konstantin Farsalinos before them, the LDN organization determined that these small discrepancies are caused by excessively high vaping temperatures – either intentional or accidental.

“Interestingly, the minority was associated with high levels of carbonyls — or carbon compounds — that the e-cigarettes generated when a lot of power was applied to their atomizer coil. The coil is the part of the vaporizer that turns its liquid into an aerosol. It must be heated to do this.”

Once again, it appears that the UK is leading the way in both vaping research and the collective support of its public health community.  Now, if only the U.S. Food and Drug Administration would follow the LDN’s courageous and scientifically-based lead, we might really have something. 

Related Article:  New Farsalinos vape study debunks old NEJM ‘formaldehyde myth’

Leave a comment

Please note, comments must be approved before they are published